September 10, 2014
1Olmsted Medical Center, Rochester, Minnesota
2University of Texas Southwestern Medical Center, Dallas
3University of North Carolina, Chapel Hill
4Thomas Jefferson University, Cardeza Foundation, Philadelphia, Pennsylvania
5University of Colorado, Denver
6University of Virginia, Charlottesville
7Foundation for Sickle Cell Disease Research, University of Miami, Miller School of Medicine, Miami, Florida
8Johns Hopkins School of Medicine, Baltimore, Maryland
9University of Florida, Gainesville
10Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
11Duke University, Schools of Nursing and Medicine, Durham, North Carolina
12Cincinnati Children’s Hospital Medical Center, Cincinatti, Ohio
13Mayo Clinic College of Medicine, Rochester, Minnesota
14National Heart, Lung, and Blood Institute, Bethesda, Maryland16Dr Goldsmith is now with the Rare Diseases Program, Office of New Drugs, US Food and Drug Administration, Bethesda, Maryland.
14National Heart, Lung, and Blood Institute, Bethesda, Maryland17Dr Ortiz is now a private senior consultant in Bethesda, Maryland.
14National Heart, Lung, and Blood Institute, Bethesda, Maryland18Dr Fulwood is now retired.
15American Institutes for Research, Silver Spring, Maryland
14National Heart, Lung, and Blood Institute, Bethesda, Maryland
JAMA. 2014;312(10):1033-1048. doi:10.1001/jama.2014.10517.